Evaluate the efficacy of a multivalent inactivated vaccine against bovine mastitis

碩士 === 國立屏東科技大學 === 動物疫苗科技研究所 === 104 === Bovine mastitis is often caused by a variety of pathogens, in which Staphylococcus aureus (S. aureus), Escherichia coli (E. coli) and Streptococcus agalactiae are the major pathogens. Infected cows may have clinical signs, including swelling, heat and pain,...

Full description

Bibliographic Details
Main Authors: Shen, You-Sheng, 沈宥陞
Other Authors: Chu, Chun-Yen
Format: Others
Language:zh-TW
Published: 2016
Online Access:http://ndltd.ncl.edu.tw/handle/48048772860063875057
id ndltd-TW-104NPUS5290002
record_format oai_dc
spelling ndltd-TW-104NPUS52900022017-07-30T04:41:33Z http://ndltd.ncl.edu.tw/handle/48048772860063875057 Evaluate the efficacy of a multivalent inactivated vaccine against bovine mastitis 評估牛乳房炎多價不活化疫苗之免疫效力 Shen, You-Sheng 沈宥陞 碩士 國立屏東科技大學 動物疫苗科技研究所 104 Bovine mastitis is often caused by a variety of pathogens, in which Staphylococcus aureus (S. aureus), Escherichia coli (E. coli) and Streptococcus agalactiae are the major pathogens. Infected cows may have clinical signs, including swelling, heat and pain, fever, depression, decreased milk production and increased number of milk somatic cells. E. coli J5 is a mutant strain of gram-negative bacteria with the completely exposed core antigen that can be easily contacted by immune cells to produce antigen-specific antibodies. S. aureus T8 is the highest ratio of isolation from cows with mastitis. In addition, S. aureus Smith compact is a mutant strain that can elicit antibodies which are able to block the attachment of S. aureus to mammary epithelial cells. Several studies have demonstrated that clumping factor A (ClfA) is a important virulence factor bond to the fibrin of host epithelial cells. In this study, we combined three strains of bacteria and one recombinant ClfA as the multivalent vaccine. The results showed that the serum antibody titer of T8/SC/J5 + rClfA-SC9 and T8/SC/J5 were significantly higher than the control (p <0.05) during 4 to 8 weeks in mouse model. The T cell proliferation index of immunized groups were also significantly higher than the control (p <0.05). In addition, the survival rate of rClfA-SC9 was higher than other groups (p <0.05) after mice challenged by E.coli No. 2 and S. aureus A476. In bovine efficacy test, serum antibody titer of immunized groups were significantly higher than the control (p <0.05) in 4 week. But the whey antibody titer and the stimulation index of PBMC were no significantly between immunized and control groups. However, the cytokines expression of immunized groups had phenomenon of upregulation. Based on the results, rClfA-SC9 still need to furher evaluate whether the potential development of mastitis vaccine. Chu, Chun-Yen 朱純燕 2016 學位論文 ; thesis 87 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 碩士 === 國立屏東科技大學 === 動物疫苗科技研究所 === 104 === Bovine mastitis is often caused by a variety of pathogens, in which Staphylococcus aureus (S. aureus), Escherichia coli (E. coli) and Streptococcus agalactiae are the major pathogens. Infected cows may have clinical signs, including swelling, heat and pain, fever, depression, decreased milk production and increased number of milk somatic cells. E. coli J5 is a mutant strain of gram-negative bacteria with the completely exposed core antigen that can be easily contacted by immune cells to produce antigen-specific antibodies. S. aureus T8 is the highest ratio of isolation from cows with mastitis. In addition, S. aureus Smith compact is a mutant strain that can elicit antibodies which are able to block the attachment of S. aureus to mammary epithelial cells. Several studies have demonstrated that clumping factor A (ClfA) is a important virulence factor bond to the fibrin of host epithelial cells. In this study, we combined three strains of bacteria and one recombinant ClfA as the multivalent vaccine. The results showed that the serum antibody titer of T8/SC/J5 + rClfA-SC9 and T8/SC/J5 were significantly higher than the control (p <0.05) during 4 to 8 weeks in mouse model. The T cell proliferation index of immunized groups were also significantly higher than the control (p <0.05). In addition, the survival rate of rClfA-SC9 was higher than other groups (p <0.05) after mice challenged by E.coli No. 2 and S. aureus A476. In bovine efficacy test, serum antibody titer of immunized groups were significantly higher than the control (p <0.05) in 4 week. But the whey antibody titer and the stimulation index of PBMC were no significantly between immunized and control groups. However, the cytokines expression of immunized groups had phenomenon of upregulation. Based on the results, rClfA-SC9 still need to furher evaluate whether the potential development of mastitis vaccine.
author2 Chu, Chun-Yen
author_facet Chu, Chun-Yen
Shen, You-Sheng
沈宥陞
author Shen, You-Sheng
沈宥陞
spellingShingle Shen, You-Sheng
沈宥陞
Evaluate the efficacy of a multivalent inactivated vaccine against bovine mastitis
author_sort Shen, You-Sheng
title Evaluate the efficacy of a multivalent inactivated vaccine against bovine mastitis
title_short Evaluate the efficacy of a multivalent inactivated vaccine against bovine mastitis
title_full Evaluate the efficacy of a multivalent inactivated vaccine against bovine mastitis
title_fullStr Evaluate the efficacy of a multivalent inactivated vaccine against bovine mastitis
title_full_unstemmed Evaluate the efficacy of a multivalent inactivated vaccine against bovine mastitis
title_sort evaluate the efficacy of a multivalent inactivated vaccine against bovine mastitis
publishDate 2016
url http://ndltd.ncl.edu.tw/handle/48048772860063875057
work_keys_str_mv AT shenyousheng evaluatetheefficacyofamultivalentinactivatedvaccineagainstbovinemastitis
AT chényòushēng evaluatetheefficacyofamultivalentinactivatedvaccineagainstbovinemastitis
AT shenyousheng pínggūniúrǔfángyánduōjiàbùhuóhuàyìmiáozhīmiǎnyìxiàolì
AT chényòushēng pínggūniúrǔfángyánduōjiàbùhuóhuàyìmiáozhīmiǎnyìxiàolì
_version_ 1718509768865218560